The vaccine adjuvant monophosphoryl lipid A is a partial agonist of TLR4

被引：0
|
作者：
Haro, Veronica Mata [1 ]
Casella, Carolyn R. [1 ]
Cekic, Caglar [1 ]
Chilton, Paula M. [1 ]
Mitchell, Thomas C. [1 ]
机构：
[1] Univ Louisville, Inst Cellular Therapeut, Louisville, KY 40202 USA
来源：
JOURNAL OF IMMUNOLOGY | 2006年 / 176卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S176 / S176
页数：1
相关论文
共 50 条
  • [31] MyD88-dependent Inhibition of TLR4/TRIF Associated Signaling after Monophosphoryl Lipid A Stimulation
    Cekic, Caglar
    Casella, Carolyn R.
    Mitchell, Thomas C.
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [32] The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for TH1 Induction
    Cauwelaert, Natasha Dubois
    Desbien, Anthony L.
    Hudson, Thomas E.
    Pine, Samuel O.
    Reed, Steven G.
    Coler, Rhea N.
    Orr, Mark T.
    PLOS ONE, 2016, 11 (01):
  • [33] Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activity
    HW Millie Fung
    Traci JT Mikasa
    Julie Vergara
    Sandra J Sivananthan
    Jeffrey A Guderian
    Malcolm S Duthie
    Thomas S Vedvick
    Christopher B Fox
    Journal of Nanobiotechnology, 11
  • [34] Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activity
    Fung, H. W. Millie
    Mikasa, Traci J. T.
    Vergara, Julie
    Sivananthan, Sandra J.
    Guderian, Jeffrey A.
    Duthie, Malcolm S.
    Vedvick, Thomas S.
    Fox, Christopher B.
    JOURNAL OF NANOBIOTECHNOLOGY, 2013, 11
  • [35] Is serum amyloid A an endogenous TLR4 agonist?
    Sandri, Silvana
    Rodriguez, Dunia
    Gomes, Eliane
    Monteiro, Hugo Pequeno
    Russo, Momtchilo
    Campa, Ana
    JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 83 (05) : 1174 - 1180
  • [36] Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
    Casella, C. R.
    Mitchell, T. C.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2008, 65 (20) : 3231 - 3240
  • [37] Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
    C. R. Casella
    T. C. Mitchell
    Cellular and Molecular Life Sciences, 2008, 65 : 3231 - 3240
  • [38] Differential requirements of CD14 and Lipopolysaccharide Binding Protein in Monophosphoryl lipid A-mediated TLR4 activation
    Tanimura, Natsuko
    Miyake, Kensuke
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [39] Solid Lipid Nanoparticle Carrier Platform Containing Synthetic TLR4 Agonist Mediates Non-Viral DNA Vaccine Delivery
    Francis, Jasmine E.
    Skakic, Ivana
    Dekiwadia, Chaitali
    Shukla, Ravi
    Taki, Aya C.
    Walduck, Anna
    Smooker, Peter M.
    VACCINES, 2020, 8 (03) : 1 - 16
  • [40] Human TLR4 polymorphism D299G/T399I alters TLR4/MD-2 conformation and response to a weak ligand monophosphoryl lipid A
    Yamakawa, Natsuko
    Ohto, Umeharu
    Akashi-Takamura, Sachiko
    Takahashi, Koichiro
    Saitoh, Shin-Ichiroh
    Tanimura, Natsuko
    Suganami, Takayoshi
    Ogawa, Yoshihiro
    Shibata, Takuma
    Shimizu, Toshiyuki
    Miyake, Kensuke
    INTERNATIONAL IMMUNOLOGY, 2013, 25 (01) : 45 - 52
12345